the Mycobacterium bovis Bacillus calmette-Guerin (BcG) vaccine is administered parenterally to infants and young children to prevent tuberculosis (tB) infection. However, the protection induced by BcG is highly variable and the vaccine does not prevent pulmonary tB, the most common form of the illness. Until improved tB vaccines are available, it is crucial to use BcG in a manner which ensures optimal vaccine performance. immunization directly to the respiratory mucosa has been shown to promote greater protection from tB in animal models. γδ t cells play a major role in host defense at mucosal sites and are known to respond robustly to mycobacterial infection. their positioning in the respiratory mucosa ensures their engagement in the response to aerosolized tB vaccination. However, our understanding of the effect of respiratory BCG vaccination on γδ t cell responses in the lung is unknown. in this study, we used a calf model to investigate the immunogenicity of aerosol BcG vaccination, and the phenotypic profile of peripheral and mucosal γδ t cells responding to vaccination. We observed robust local and systemic M. bovis-specific IFN-γ and IL-17 production by both γδ and CD4 T cells. Importantly, BCG vaccination induced effector and memory cell differentiation of γδ t cells in both the lower airways and peripheral blood, with accumulation of a large proportion of effector memory γδ t cells in both compartments. our results demonstrate the potential of the neonatal calf model to evaluate tB vaccine candidates that are to be administered via the respiratory tract, and suggest that aerosol immunization is a promising strategy for engaging γδ t cells in vaccine-induced immunity against tB.
of other lymphocyte populations, notably γδ T cells, may represent another major essential component for protection or resistance to TB [reviewed 24 ].
γδ T cells play a major role in defense against pathogens, especially at mucosal sites such as the lung [25] [26] [27] [28] . Although γδ T cells fall into the innate-like category, adaptive features have also been reported in multiple studies [reviewed 29, 30 ]. Humans vaccinated parenterally with BCG have a population of γδ T cells that expands robustly in response to in vitro restimulation with mycobacteria antigens 31 . In non-human primates, administration of phosphoantigens/IL-2 induced a marked expansion and pulmonary accumulation of phosphoantigen-specific Vγ2Vδ2 T cells, significantly reducing M. tb burdens and associated lung pathology 9, 32 .
Like CD4 T cells, γδ T cells have the capacity to differentiate into subsets that differ in their migratory and functional properties. In humans, γδ T cell subsets are divided according to the surface expression of CD45RA and CD27. Naïve CD45RA + CD27 + cells represent ~10-20% of the γδ T cells circulating population in healthy adults. Central memory (T CM ) cells CD45RA − CD27 + are more plentiful in the blood and exhibit robust proliferative capacity, but limited effector functions 33 . Effector memory (T EM ) and CD45RA + CD27 − (T EMRA ) γδ T cells are generally recognized to be fully differentiated subsets and express receptors for homing to inflamed tissues, display immediate effector functions and are highly prevalent in sites of inflammation 34 . Consistent with their differential homing capacity, certain chemokine receptors are also useful for classifying functional γδ T cell subsets 35 . The expression of the homing receptors CXCR3, CCR5 and CD62L have been used to differentiate effector and memory γδ T cells subsets 36, 37 .
Effector T cells expand during active disease, whereas memory cells correlate with reduced mycobacterial burden and associated pathology following experimental infection 38, 39 . Interestingly, serious TB disease results in reduced γδ T cell effector functions in the periphery 33, 34 . Consistent with this observation, there is a progressive loss of CD27 neg T EM and T EMRA γδ T cell subsets from the peripheral blood of patients with active TB 34, 40 . We have recently shown that virulent M. bovis infection results in differentiation of circulating bovine γδ T cells to a T CM phenotype similar to that described in humans 41 . However, little is known regarding the response by γδ T cells in the respiratory tract during mycobacterial infection and vaccination 42, 43 , and there are limitations for assessing the biological significance of γδ T cells in the response to TB in humans.
As a natural host of TB infection, cattle represent a highly relevant animal model to investigate the immune response of γδ T cells to mycobacterium vaccination and infection 2, 44, 45 . Furthermore, respiratory BCG vaccination is an established, well-characterized experimental system that is particularly useful for studying the development of TB-specific immune responses in the lungs. Serial bronchoalveolar lavages can be conducted in cattle, which allow longitudinal analysis of the cell populations which are recruited to the lungs following aerosol vaccination, and which have been implicated in promoting increased resistance to TB infection. To this end, calves were vaccinated with BCG via the respiratory tract, and vaccine immunogenicity, and the differentiation of responding M. bovis-specific γδ T cells was examined in the peripheral blood and lower respiratory tract. We hypothesized that vaccination with BCG via the respiratory tract would result in the development of robust immune responses and phenotypic changes in local and circulating γδ T cell populations. Improved characterization of γδ T cell phenotype and function during mycobacterial infection and vaccination will contribute to the development of improved strategies for harnessing their response in protection against TB.
Results

Aerosol BcG vaccination induced robust local and systemic cellular immune responses. One
of the primary objectives of this study was to determine the immunogenicity of a BCG vaccine delivered by aerosol to cattle. To this end, calves were vaccinated via aerosol inoculation with BCG. Control calves remained unvaccinated. PBMC were isolated at 4, 8, 12-and 16-weeks post vaccination ( Fig. 1A ). Cells were restimulated in vitro as described in Materials & Methods. IFNγ (upper panels) and IL-17A (lower panels) concentrations were analyzed in cell culture supernatants by sandwich ELISA. Aerosol immunization was highly immunogenic and elicited potent M. bovis-specific immune responses in peripheral blood, as indicate by the robust IL-17A and IFNγ secretion by Ag-stimulated PBMC. The response was significantly increased over PBMC from unvaccinated controls throughout the 16-week study (Fig. 1A) .
Vaccine-induced responses in the respiratory mucosa were measured from BAL mononuclear cells at 4-, 12and 16-weeks post vaccination ( Fig. 1B ). BAL cells from BCG vaccinated calves produced significant quantities of IL-17A and IFNγ in recall response to PPD-b, while BAL cells from unvaccinated animals did not ( Fig. 1B) .
Vaccine-induced cellular immune responses were also evaluated in cells harvested from lung-draining lymph nodes during necropsy, 16 weeks after vaccination ( Fig. 2 ). Single cell suspensions were prepared from the mediastinal and tracheobronchial LN, and in vitro antigen stimulation assays were performed as described in Materials & Methods. Cell culture supernatants were analyzed by sandwich ELISA for IFNγ (upper panels) and IL-17A (lower panels). Similar to the results from the BAL, cells isolated from the tracheobronchial ( Fig. 2A ) and mediastinal LNs (Fig. 2B ) of BCG-vaccinated calves secreted IFNγ and IL-17A in specific response to in vitro PPD-b restimulation and the response was significantly increased over samples from unvaccinated controls at 16 week's post vaccination.
Aerosol BCG vaccination elicits effector and central memory T cell responses. Ex vivo assays are
considered a measure of effector memory T cell responses. While most TB vaccines elicit ex vivo IFNγ responses, it is clear that not all vaccines that induce this response provide protection 2 . Long-term cultured IFNγ ELISPOT responses to TB vaccination negatively correlate with mycobacterial burden and TB-associated pathology and positively correlate with vaccine-induced protection [46] [47] [48] [49] . In cattle and humans, the long-term cultured IFNγ ELISPOT assay evaluates central memory T cell responses following TB infection and vaccination 38, 39 . Here, we determined if aerosol BCG vaccination was capable of eliciting both ex vivo and long-term cultured responses, as has been previously reported for other protective TB vaccines 39, 46, 47 .
Aerosol BcG vaccination induces a robust systemic and mucosal antigen-specific γδ t cell responses. Having demonstrated that BCG vaccination via the respiratory tract elicited effector and memory
T cell responses in the calf, we next investigated the differentiation status of the responding γδ T cell populations. Using flow cytometry, we assessed mycobacterial-specific γδ T cell responses in the peripheral and lung compartment. It is well established that aerosol BCG vaccination induces effector and memory CD4 T cell differentiation 53 ; therefore, where relevant, we made comparisons to the M. bovis-specific CD4 T cell populations in the same animals. The frequency of vaccine-elicited IFNγ-producing γδ T cells was determined by intracellular cytokine staining on PBMC and BAL cells after ~8 weeks post vaccination. Aerosol BCG vaccination induced M. bovis-specific, IFNγ-producing γδ T cells in both the peripheral and mucosal compartments (Fig. 5A ). The frequency of γδ T cells producing IFNγ in response to PPD-b stimulation was significantly higher in animals that were vaccinated with BCG compared to unvaccinated controls. Similarly, aerosol vaccination induced IFN-γ-producing antigen-specific CD4 T cells in the peripheral and mucosal compartment ( Fig. 5B ). Thus, aerosol BCG vaccination induces functional, M. bovis-specific γδ T cells in both the lung and periphery.
M. bovis-specific γδ t cells from BcG vaccinated calves adopt a memory phenotype based on CD27 and CD45R expression. We have recently shown that virulent M. bovis infection in cattle promotes
the differentiation of circulating γδ T cells into subsets that share characteristics with human T CM γδ T cells (CD45R-CD27 + CD62L hi ) 41 . Here, we investigated the phenotype of both systemic and lung-associated γδ T cells to determine the impact of aerosol BCG vaccination on γδ T cell differentiation.
In the circulating compartment, aerosol BCG vaccination induced a significant increase in γδ T cells with a T CM (CD45R − CD27 + ) phenotype, and a moderate increase in γδ T cells with a T EM (CD45R − CD27 + ) phenotype (Fig. 6A ). The cumulative proportions of effector/memory γδ T cells from all calves are shown in Fig. 6B . Our results suggest that BCG vaccination, similar to virulent M. bovis infection, elicits a γδ T CM phenotype in the circulation that comprises the majority of the M. bovis-specific proliferative response. Interestingly, however, in contrast to our previous studies with virulent M. bovis infection, BCG vaccination also induced the expansion of circulating γδ T cells with a T EM (CD45R − CD27 + ) phenotype.
In the mucosal compartment, we observed that aerosol BCG vaccination preferentially induced the differentiation of γδ T EM (CD45R − CD27 + ) cells, with low proportions of T CM cells compared to the circulating population ( Fig. 7A ). The relative contribution of lung γδ T cell subsets in the response to PPD-b are shown in Fig. 7B .
Thus, BCG vaccination via the respiratory route induces the differentiation of antigen-specific γδ T cells with a T CM phenotype in the periphery, and a T EM phenotype in the airways.
M. bovis-specific γδ T cells modulate expression of the tissue-associated chemokine receptors CXCR3 and CCR5. Expression of the chemokine receptors CXCR3 and CCR5 has been used to differentiate
effector and memory T cell subsets (35) . We have previously shown that circulating γδ T cells modulate their expression of CXCR3 and CCR5 during virulent M. bovis infection 41 . The increased expression of CCR5 and CXCR3 on M. bovis-responsive T cells is expected to enable these populations to migrate into the inflamed tissue. www.nature.com/scientificreports www.nature.com/scientificreports/ Therefore, we next investigated the effect of aerosol BCG vaccination on the acquisition of lung homing receptors by M. bovis responsive γδ T cell in peripheral blood and BAL cells.
We observed marked differences in the patterns of chemokine receptor expression by M. bovis-responsive γδ T cells isolated from mucosal versus peripheral compartments. The majority of M. bovis-specific γδ T cells recovered from the BAL expressed lower surface levels of CXCR3 compared to non-responding γδ T cells ( Fig. 8A ). As seen in Fig. 8B , airway antigen-specific CD4 T cells also expressed lower levels of CXCR3 compared to nonresponsive CD4 T cells. Comparison of chemokine receptor expression by mucosal γδ T cells compared with circulating M. bovis-specific γδ T cells, revealed significantly higher expression of CXCR3 by circulating antigen-specific populations (Fig. 9C ). The expression of CCR5 on both CD4 and γδ T cells followed a similar trend, with increased expression by circulating, M. bovis-specific cells and reduced by M. bovis-responsive T cells reovered from the airways; however, this change was not statistically significant (Supp. Fig. 6 ). Together our data show that aerosol BCG vaccination induces up-regulation of CXCR3 by circulating γδ T cells, which may confer lung homing properties under inflammatory conditions and correlate with the observed effector memory phenotype (Fig. 7) 36 . Conversely, analysis of airway, M. bovis-responsive γδ T cells indicates a tendency towards downregulation of chemokine receptor expression, perhaps indicating that T cells localized to the lung no longer require these receptors.
Discussion
Current vaccine regimens against TB are ineffective; thus, development of improved intervention strategies and a better understanding of the nature of protective immunity remain important goals for TB research. Vaccination via the respiratory tract has been demonstrated to induce significant protection against virulent mycobacterial challenge [4] [5] [6] [7] [8] [9] . Although Th1 cells are of major importance for immunity to TB, other immune populations, notably γδ T cells [ 9, 31, 54, 55 and reviewed 24 ], may represent another essential component for the anti-mycobacterial immune response. The focus of this study was to investigate the immunogenicity, and generation of systemic and local γδ T cell responses to BCG vaccination via the respiratory tract.
Infants are an important target population for TB vaccination. However, the infant immune system represents significant challenges when designing vaccines [reviewed 56 ]. There are few suitable models suitable for studying infant immunology to TB, and most mucosal TB vaccines have been studied in adult animals. Although we often attempt to extrapolate our knowledge of host defense and vaccine-induces immunity from adults to infants, we currently know little about neonatal immune response to mucosal vaccination. Furthermore, despite the promise of a vaccine strategy, there are safety concerns associated to the administration of a live replicating pathogen directly to the respiratory mucosa of immunosuppressed individuals. Thus, a reliable animal model that reflects the immune response to this route of vaccination in human infants is urgently required. Here, we observed that aerosol BCG immunization of young calves is highly immunogenic and induces antigen-specific immune responses in both the systemic and local compartment (Figs 1 and 2 ). Our results are consistent with those reported by Hoft et al., showing that oral delivery of BCG to humans induced both systemic and mucosa-associated immune responses in the airways 57 . The capacity of aerosol BCG vaccination to induce responses in both the systemic and local immune compartments in cattle is in contrast to the observations made in mice, where vaccine responses are compartmentalized following mucosal vaccination 58 . In non-human primates, responses are less compartmentalized, but the magnitude of response correlates with the route of vaccination, with strong systemic responses after systemic vaccination and strong responses in the respiratory tract in www.nature.com/scientificreports www.nature.com/scientificreports/ animals immunized by aerosol delivery 5 . Given the limitations of other animal models, our results are encouraging and demonstrate the potential of the calf model to evaluate the safety and immunogenicity of other TB vaccine candidates through this route of immunization.
In parallel with efforts to evaluate the immunogenicity of the aerosol route of delivery, the identification of immunological correlates of protection is essential to reduce costs of challenge experiments and to prioritize vaccine candidates. Assessing the magnitude and frequency of IFNγ-producing CD4 T cells has remained the standard measurement of vaccine induced T cell memory for many years. However, it has become clear recently that this ex vivo assay cannot consistently predict vaccine success 59 . Alternatively, long-term cultured IFNγ ELISPOT responses to TB vaccination have been shown to negatively correlate with mycobacterial burden and TB-associated pathology, and to positively correlate with vaccine success [46] [47] [48] 50, 60 . In humans and cattle, the cultured ELISPOT assay is a surrogate of T CM responses 39, 46, 47 . Using this assay and the conventional ELISPOT, we evaluated if aerosol BCG vaccination was capable of eliciting both effector and T CM responses. Consistent with the results of previous bovine TB vaccine trials examining parenteral BCG vaccination 46, 48 , we demonstrate here that aerosol BCG vaccination elicits significant long-term cultured IFNγ ELISPOT responses to both PPD-b and the protein antigens Tb10.4 and Ag85a (Fig. 3 ). Thus aerosol BCG vaccination elicits effector and central memory T cell (T CM ) responses in both humans and cattle 39, 48, 51, 52 .
In humans, serious TB infection induces expansion of phenotypically immature, T CM Vγ9Vδ2 T cells, and a reduction in the pool of Vγ9Vδ2 T cells with immediate effector functions (T EM and T EMRA cells), suggesting a functional impairment of γδ T cells perhaps, due to a persistent stimulation 61 . Similarly, we have recently reported that virulent M. bovis infection in cattle can significantly alter the differentiation of circulating M. bovis-specific γδ T cells towards a T CM (CD45R-CD27 + CD62L hi ) phenotype 41 . In this study, phenotypic analyses of circulating γδ T cells showed that M. bovis-specific γδ T cells are strongly affected by BCG vaccination; however, in contrast to virulent infection, the vaccine strain induced the expansion of both T CM and T EM γδ T cells in the blood (Fig. 6 ). As particular memory subsets of CD4 T cells have been shown to correlate with reduced mycobacterial burden, or to indicate disease progression, we speculate that changes in the differentiation status of memory γδ T cell subsets may also be indicative of particular disease states or serve as a correlate of immune status.
Previous reports in humans have shown that T EM γδ T cells are highly represented in sites of inflammation and display immediate effector functions 33 . Consistent with these findings, BCG vaccination via the respiratory tract was associated with an increase in airway IFNγ + γδ T cells ( Fig. 5 ) which exhibited a T EM phenotype (Fig. 7) . In non-human primates, accumulation of phosphoantigen-specific Vγ2Vδ2 T cells in the lungs significantly reduces M. tb burden and associated lung pathology 9, 28 . Similarly, in mice, M. bovis BCG intranasal infection elicits increased levels of IFNγ + γδ T cells with cytotoxic activity against infected macrophages 42 . Thus, accumulation of T EM M. bovis-responsive γδ T cells in the airway mucosa may enable an immediate response upon pathogen re-exposure. Identifying strategies to elicit memory γδ T cell differentiation with a high frequency of γδ T cell effectors in the lung, as well as peripheral mycobacteria-specific γδ T cells that have the capacity to rapidly traffic into the lung to enhance and sustain protection, may be expected to confer optimal vaccine-induced protection 38, 39 Few studies have examined γδ T cell chemokine expression 33 ; however, mycobacterial antigen stimulation appears to alter γδ T cell chemokine receptor expression 37 . In our previous studies, we have observed increased expression of both CXCR3 and CCR5 on circulating γδ T cells from cattle infected with virulent M. bovis 41 . Similarly, we show here that aerosol BCG vaccination is associated with an increase in surface expression of CXCR3 in circulating M. bovis-specific γδ T cells compared to non-responding cells (Fig. 9 ). CXCL10, the ligand of CXCR3, is involved in trafficking of Th1 lymphocytes to areas of inflammation. It has been shown that peripheral human Vγ2Vδ2 CXCR3 + T cells are recruited efficiently by CXCL10 37, 62 . Moreover, CXCL10 is found in vivo in lymph nodes and TB granulomas 63 , suggesting that CXCR3 expression in circulating γδ T cells may enable rapid migration to the lungs upon M. bovis challenge 64, 65 . Interestingly, comparison of CXCR3 expression on circulating T cell populations with M. bovis-specific T cells recovered from the BAL on the same day, revealed significantly reduced surface expression by both γδ and CD4 T cells in the airways (Fig. 9A,B) . These findings are intriguing, as Poggi et al. showed that the homeostatic chemokine CCL21 was more efficient at inducing transendothelial migration of lung-resident Vγ2Vδ1 CXCR3 + T cell populations than inflammatory CXCL10, suggesting that lung-associated γδ T cells preferentially respond to homeostatic chemokines, while circulating Vγ2Vδ2 CXCR3 + T cells are more sensitive to inflammatory chemokines and thus might not require high expression of www.nature.com/scientificreports www.nature.com/scientificreports/ CXCR3 62 . It may also be possible that CXCR3 is internalized or shed by cells which have migrated to the lung, thus explaining the reduced surface expression. Functional studies to assess CXCR3-dependent lymphocyte trafficking were not performed in this study, thus its importance in facilitating γδ T cell recruitment during M. bovis infection in the bovine remains to be fully determined.
BCG remains the most efficacious, 'gold-standard' TB vaccine available to prevent TB in humans and animals. Therefore, until improved vaccines are available, it is crucial to identify the most effective strategies for using BCG. As observed here, mucosal vaccination in juvenile calves is immunogenic, priming robust effector and memory Mycobacterium-specific T cell responses in both peripheral and lung compartment. Based on our observations, there is merit in evaluating this route of immunization using other vaccine candidates, and in employing the infant calf model, as it can provide critical insights into local TB-specific immune responses in infant humans. Through a comparative assessment of the phenotype and functions of M. bovis-specific γδ T cells in the systemic and mucosal compartment, we have shown that a single BCG immunization via the respiratory tract induces differentiation of T CM and T EM M. bovis-responsive γδ T cells, with a predominance of T EM γδ T cells in the lungs, where they would be expected to mediate immediate effector functions and rapid protection against TB invasion. γδ T cells are known to promote resistance to Mycobacterium infection 9,10,32 . Thus, engaging γδ T cells through novel, aerosol vaccination strategies may be particularly beneficial for promoting local protection in the respiratory tract.
Materials and Methods
Animal use ethics. All animal procedures were conducted in strict accordance with federal and institutional guidelines and were approved by the Kansas State University Institutional Animal Care and Use Committee (Protocol Number: 27-2956). A total of 28 Holstein steers (~6-8-week-old) were used in the following experiments. Animals were housed in outdoor pens at the College of Veterinary Medicine, Kansas State University in Manhattan, KS. Animals had ab libitum access to hay, water, and concentrate. Steps were taken to avoid prolonged restraint and discomfort during all handling procedures. Body temperature was assessed if animal demonstrated signs of clinical illness and antibiotics and analgesics were administered as needed if animals presented with clinical disease independent of the experimental protocol. At the end of the study animals were humanely euthanized by barbiturate overdose. The calves showed no clinical signs following administration of the vaccine, and we observed no pathological changes in the lungs or tissues of the respiratory tract at euthanasia.
Mycobacterium bovis BcG aerosol vaccine procedures. M. bovis BCG Danish strain was a gift
from Dr. Ray Waters at the National Animal Disease Center, USDA. BCG was prepared using standard techniques in Middlebrook 7H9 liquid media (Becton Dickinson, Franklin Lakes, NJ) supplemented with 10% oleic acid-albumin-dextrose complex (OADC) plus 0.05% Tween 80 (Sigma, St. Louis, Missouri). For the first experiment, treatment groups consisted of non-vaccinated steers (n = 3) and animals receiving 1 × 10 8 colony-forming units (CFU) of M. bovis BCG Danish strain (n = 11). For the second study, treatment groups consisted of non-vaccinated calves (n = 7) and animals receiving 1 × 10 8 CFU of M. bovis BCG Danish strain (n = 7). For both studies, BCG inoculum was delivered to restrained calves by aerosol as described by Palmer et al. 66 . Briefly, inoculum was nebulized into a mask (Trudell Medical International, London, ON, Canada) covering the nostrils and mouth, allowing regular breathing and delivery of the bacterial inoculum to the respiratory tract. Clinical signs, including cough, dyspnea, and loss of appetite were monitored daily throughout the study. No clinical signs or pathology associated with BCG immunization were observed. pBMc isolation. Peripheral blood was drawn from the jugular vein into 2 × acid-citrate-dextrose solution. For peripheral blood mononuclear cells (PBMC) isolation, blood was diluted 1:1 in phosphate-buffered saline (PBS), cells were collected from buffy coat fractions, and PBMCs were isolated by density centrifugation on Histopaque (Sigma). Contaminating red blood cells were removed using RBC lysis buffer. Finally, cells were washed three times, counted in an hemocytometer and resuspended in complete RPMI (cRPMI) composed of RPMI-1640 (Gibco, Carlsbad, CA) supplemented with 2 mM L-glutamine, 25 mM HEPES buffer, 1% 
Bronchoalveolar lavage fluid collection and cell isolation. Broncheoalveolar lavage (BAL) samples
were collected using a modified stallion urinary catheter (JorVet, Jorgensen Laboratories). The catheter was blindly passed through the nose and advanced through the trachea until lodging in the bronchus. A total of 180 mL of sterile saline was divided into three aliquots. An aliquot was first introduced to the lower respiratory tract, followed by immediate suction to obtain lower airway washes. The procedure was repeated twice more. All three aliquots were pooled at the end of the procedure. BAL samples were kept on ice, filtered over sterile gauze, and centrifuged at 200 × g for 10 minutes at 4 °C. Contaminating red blood cells were removed using RBC lysis buffer. Cells were washed, resuspended in cRPMI, counted and 1 × 10 6 cells/well were resuspended in cRPMI and plated in 96 well plates. Subsequently, BAL cells were cultured for 6-days at 37 °C, in the presence of 5% CO2, and stimulated with M. bovis PPD (PPD-b, 200 IU/mL, Prionics Ag, Sclieren, Switzerland). Concanavalin A mitogen (ConA, 5 µg/ml, Sigma) or cRPMI medium were used as positive and negative control, respectively. Plates were incubated for 72 hours for cytokine measurement at 37 °C, 5% CO 2 incubator. tissue collection and cell suspension. All calves were euthanized 16 weeks after vaccination by intravenous administration of barbiturate overdose. Tissues were examined for gross lesions. Mediastinal and tracheobronchial lymph node tissues were collected and placed in cold cRPMI. Cells from lymph nodes were gained by sieving small pieces of tissue through steel meshes. Contaminating red blood cells were removed using RBC lysis buffer. Finally, cells were washed three times, counted in a hemocytometer and resuspended in cRPMI. Subsequently, cells (5 × 10 5 /well) were plated in round-bottom 96-well plate in duplicates, cultured for 6-days at www.nature.com/scientificreports www.nature.com/scientificreports/ 37 °C, in the presence of 5% CO 2 , and stimulated with M. bovis PPD (PPD-b, 200 IU/mL, Prionics Ag, Sclieren, Switzerland),Concanavalin A mitogen (ConA, 5 µg/ml, Sigma) or cRPMI medium were used as positive and negative control, respectively.
Long-term cell culture and eLiSpot. Following PBMC isolation, long-term cell culture was performed as described by Maggioli et al. 39, 50 . Briefly, PBMC were cultured (2 × 10 6 cells/well) in 24 well flat-bottom microtiter plates (Nunc, Thermo Fisher, Waltham, MA) and stimulated with a cocktail of M. bovis PPD (PPD-b, 200 IU/ml, Prionics Ag, Sclieren, Switzerland), rTB10.4 and rAg85A (1 μg/ml each) in cRPMI medium for 12 days 37 °C, 5% CO 2 . Media containing human rIL-2 (Sigma, 10 IU/ml) was used to replace media from the PBMC cultures at days 3 and 7. Fresh media without IL-2 was used at days 10 and 12. At day 13, autologous APCs were isolated by adherence incubating 2 × 10 5 /well of freshly isolated PBMC in complete medium at 37 °C, 5% CO 2 for 90 min in 96-well ELISPOT plates (Millipore, Watford, UK) previously coated overnight with anti-bovine IFNγ capture-mAb (Kingfisher) and blocked in cRPMI, for 2 h at 37 °C, 5% CO 2 . Non-adherent cells were discarded, and the adherent cells washed twice times with warm cRPMI. Long-term cell cultures and antigen cocktail were added (2 × 10 4 /well) to the ELISPOT plate and incubated for 20 h at 37 °C, 5% CO 2 in the presence of autologous APC.
Ex vivo eLiSpot. The IFNγ and IL-17A ELISPOT assay was performed as described by Maggioli et al. 39, 50 .
Briefly, 96-well ELISPOT plates (Millipore) were coated at 4 °C overnight with an anti-bovine IFNγ capture mAb or IL-17A capture mAb (both from Kingfisher Biotech, Inc., St. Paul, MN), followed by a blocking step in cRPMI, for 2 h at 37 °C, 5% CO 2 . Fresh isolated PBMC or long-term cultured cells (2 × 10 4 /well) were added to ELISPOT plates and stimulated with either PPD-b (5 μg/ml), rTB10.4 and rAg85A (1 μg/ml each), ConA (5 µg/ml) or medium alone. Plates were incubated 20 h (IFNγ) or 48 h (IL-17A) at 37 °C, 5% CO 2 . Spot forming cells (SFC) were detected following the Vectastain ABC-AP Kit (Vector Laboratories, Burlingame, CA) standard procedures.
proliferation. Isolated PBMC were labeled using CellTrace Violet (Invitrogen, Carlsbad, CA) prior to cell culture following manufacturer's instructions. Briefly, freshy isolated PBMCs were resuspended at 1 × 10 7 cells/ mL in PBS containing 10 μM/ml of the CellTrace dye. After gently mixing, PBMCs were incubated for 20 min at 37 °C in a water-bath. Labeling was quenched by using an equal volume of FBS, and cells were washed three times with RPMI medium. Subsequently, cells (5 × 10 5 /well) were plated in round-bottom 96-well plate in duplicates, cultured for 6-days at 37 °C, 5% CO 2 , in the presence of M. bovis PPD (PPD-b, 200 IU/mL). ConA (5 µg/ml) or cRPMI medium were used as positive and negative control, respectively. After six days, cells were surface stained (see Flow cytometry section) and analyzed for proliferation and surface marker expression by flow cytometry. flow cytometry. Following the appropriate culture duration, cells were stained with primary and secondary monoclonal antibodies (mAbs) listed on Table 1 . All incubation steps for staining were performed in FACS buffer (PBS with 10% FBS and 0.02% NA-azide) and incubated for 25 min at 4 °C. Cells were washed and fixed with BD FACS lysis buffer (BD Biosciences, Mountain View, CA) for 10 min at room temperature, washed and resuspended in FACS buffer until analysis.
For intracellular staining, 1 × 10 6 cells were incubated in cRPMI containing PPD-b for 16 h at 37 °C, 5% CO 2 with Brefeldin A (GolgiPlug; BD Pharmingen, 10 μg/ml) added at 4 h of culture. After staining cell-surface markers, cells were permeabilized for 30 min using BD CytoFix/CytoPerm solution (BD Biosciences) and incubated with IFNγ (Table 1) eLiSA. PBMC and BAL cells were stimulated in vitro with PPD-b as described above. Plates were incubated for 6 days (PBMC) or 72 hours (BAL) at 37 °C, 5% CO 2 incubator. Cell culture supernatants were stored at −80 °C until ELISA analysis. The concentration of cytokines in cell culture supernatants was determined using bovine commercial ELISA kits for IFNγ, and IL-17A (all from Kingfisher) according to manufacturer's instructions. Each sample assayed was measured in duplicate.
Statistical analyses
Results are expressed as averages ± standard errors of the mean (SEM). Statistical significance was determined by one-way Analysis of Variance (ANOVA) followed by Bonferroni test, or Student's t test using Prism software (GraphPad, La Jolla, CA).
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
